Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06225843
Title Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis (EGIA-003)
Acronym EGIA-003
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Alethia Biotherapeutics
Age Groups: senior | adult
Covered Countries CAN

Additional content available in CKB BOOST